Open
SectorHealthcare
136.03 -0.68
24h
Min
136.02
Max
137.75
Income | 100M 108M |
---|---|
Sales | 115M 688M |
P/E Sector Avg | 41.997 35.739 |
Profit margin | 15.636 |
Employees | 1,800 |
EBITDA | 129M 153M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +22.86% upside |
Next Earnings | 29 paź 2025 |
---|
Market Cap | 679M 14B |
---|---|
Previous open | 136.71 |
Previous close | 136.03 |
By Acuity
21%
79%
44 / 371 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 168 USD 22.86%
High 200 USD
Low 124 USD
Based on 26 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$